Cargando…

Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma

The present study aimed to screen the immune-related genes (IRGs) in patients with liver hepatocellular carcinoma (LIHC) and construct a synthetic index for indicating the prognostic outcomes. The bioinformatic analysis was performed on the data of 374 cancer tissues and 50 normal tissues, which wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Weidong, Feng, Lanyun, Dong, Shu, Ning, Zhouyu, Hua, Yongqiang, Liu, Luming, Chen, Zhen, Meng, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327182/ https://www.ncbi.nlm.nih.gov/pubmed/32579175 http://dx.doi.org/10.1042/BSR20194240

Ejemplares similares

FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1
por: Shi, Weidong, et al.
Publicado: (2020)

CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Luo, Jun-peng, et al.
Publicado: (2021)

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature
por: Zhao, Kaifei, et al.
Publicado: (2020)

Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023)

Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2020)

Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression
por: Shi, Weidong, et al.
Publicado: (2019)

CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis
por: Shi, Weidong, et al.
Publicado: (2021)

Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma
por: Qi, Zhenhua, et al.
Publicado: (2020)

CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Single-cell transcriptome analysis revealed the immune profile of PD-1 blockade in gallbladder carcinoma liver metastasis
por: Xie, Lin, et al.
Publicado: (2023)

Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma
por: Wang, Zhonghao, et al.
Publicado: (2017)

The prognostic significance of KLRB1 and its further association with immune cells in breast cancer
por: Xu, Ning, et al.
Publicado: (2023)

From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma
por: Yang, Hong, et al.
Publicado: (2017)

DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma
por: Li, Ming, et al.
Publicado: (2020)

Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma
por: Rong, Min-hua, et al.
Publicado: (2020)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer
por: Sun, Lei, et al.
Publicado: (2021)

A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma
por: Yang, Jingze, et al.
Publicado: (2023)

Diagnostic and prognostic values of upregulated SPC25 in patients with hepatocellular carcinoma
por: Yang, Xiaolin, et al.
Publicado: (2020)

Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma
por: Shi, Ting, et al.
Publicado: (2022)

EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification
por: Meng, Zhi-Yong, et al.
Publicado: (2023)

Explore prognostic biomarker of bladder cancer based on competing endogenous network
por: Li, Faping, et al.
Publicado: (2020)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma
por: Ma, Xi, et al.
Publicado: (2020)

Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2021)

Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma
por: Wei, Ran, et al.
Publicado: (2023)

EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer
por: Ke, Bin, et al.
Publicado: (2023)

Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma
por: Wan, Sizhe, et al.
Publicado: (2020)

Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma
por: Wang, Qingqing, et al.
Publicado: (2021)

The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis
por: Min, Zhao, et al.
Publicado: (2021)

Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data
por: Ye, Guanzhi, et al.
Publicado: (2019)

Prognostic value of immune checkpoint molecules in breast cancer
por: Fang, Jun, et al.
Publicado: (2020)

Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1
por: Wang, Shi-shuo, et al.
Publicado: (2020)

PGM5: a novel diagnostic and prognostic biomarker for liver cancer
por: Jiao, Yan, et al.
Publicado: (2019)

Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma
por: Ma, Linkun, et al.
Publicado: (2019)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2020)

Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma
por: Shang, Bing-Bing, et al.
Publicado: (2021)

Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer
por: Feng, Lanyun, et al.
Publicado: (2018)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vmr4ifi2952iih57rf0g8ubtd2